OA09023A - Pharmaceutical composition, which can be administered orally, intended to reduce the effects of b-lactams. - Google Patents

Pharmaceutical composition, which can be administered orally, intended to reduce the effects of b-lactams.

Info

Publication number
OA09023A
OA09023A OA59487A OA59487A OA09023A OA 09023 A OA09023 A OA 09023A OA 59487 A OA59487 A OA 59487A OA 59487 A OA59487 A OA 59487A OA 09023 A OA09023 A OA 09023A
Authority
OA
OAPI
Prior art keywords
lactams
effects
intended
reduce
pharmaceutical composition
Prior art date
Application number
OA59487A
Other languages
French (fr)
Inventor
Tancrede Cyrille
Andremont Antoine
Labia Roger
Leonard Florence
Original Assignee
Roussy Inst Gustave
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roussy Inst Gustave filed Critical Roussy Inst Gustave
Publication of OA09023A publication Critical patent/OA09023A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Mycology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
OA59487A 1987-04-10 1988-12-09 Pharmaceutical composition, which can be administered orally, intended to reduce the effects of b-lactams. OA09023A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8705110A FR2613624B1 (en) 1987-04-10 1987-04-10 ORAL ADMINISTRATIVE PHARMACEUTICAL COMPOSITION FOR REDUCING THE EFFECTS OF B-LACTAMINES

Publications (1)

Publication Number Publication Date
OA09023A true OA09023A (en) 1991-03-31

Family

ID=9350003

Family Applications (1)

Application Number Title Priority Date Filing Date
OA59487A OA09023A (en) 1987-04-10 1988-12-09 Pharmaceutical composition, which can be administered orally, intended to reduce the effects of b-lactams.

Country Status (8)

Country Link
EP (1) EP0309532A1 (en)
JP (1) JPH01503537A (en)
AU (1) AU604117B2 (en)
FR (1) FR2613624B1 (en)
OA (1) OA09023A (en)
PT (1) PT87190B (en)
WO (1) WO1988007865A1 (en)
ZA (1) ZA882426B (en)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI920206A0 (en) * 1992-01-17 1992-01-17 Pekka Untamo Heino MEDICINSK ANVAENDNING, MEDICINSKT FOERFARANDE OCH PREPARAT.
FR2843302B1 (en) 2002-08-09 2004-10-22 Centre Nat Rech Scient GALENIC FORM FOR COLLECTIVE DELIVERY OF ACTIVE PRINCIPLES
US8273376B2 (en) 2006-11-17 2012-09-25 Da Volterra Colonic delivery of metallo-dependent enzymes
FI20105572A0 (en) 2010-05-24 2010-05-24 Prevab R Lcc Modified beta-lactamase and methods and uses related thereto
GB201117313D0 (en) 2011-10-07 2011-11-16 Gt Biolog Ltd Bacterium for use in medicine
GB201306536D0 (en) 2013-04-10 2013-05-22 Gt Biolog Ltd Polypeptide and immune modulation
EP3132033B1 (en) 2014-04-17 2019-10-30 Synthetic Biologics, Inc. Beta-lactamases with improved properties for therapy
CA2958755C (en) 2014-08-28 2023-02-28 Synthetic Biologics, Inc. E. coli-based production of beta-lactamase
CN107148473B (en) 2014-10-08 2021-08-06 合成生物制品有限公司 Beta-lactamase formulations and uses thereof
WO2016105498A1 (en) 2014-12-23 2016-06-30 Synthetic Biologics, Inc. Methods and compositions for inhibiting or preventing adverse effects of oral antibiotics
SI3193901T1 (en) 2014-12-23 2018-06-29 4D Pharma Research Limited Pirin polypeptide and immune modulation
NO3065748T3 (en) 2014-12-23 2018-04-21
JP6810697B2 (en) 2015-02-23 2021-01-13 シンセティック・バイオロジクス・インコーポレイテッド Carbapenemase used with antibiotics to protect the intestinal microbiome
US10709773B2 (en) 2015-03-06 2020-07-14 Synthetic Biologics, Inc. Safe and effective beta-lactamase dosing for microbiome protection
SG10201912324XA (en) 2015-06-15 2020-02-27 4D Pharma Res Ltd Compositions comprising bacterial strains
ME03563B (en) 2015-06-15 2020-07-20 4D Pharma Res Ltd Compositions comprising bacterial strains
MA41060B1 (en) 2015-06-15 2019-11-29 4D Pharma Res Ltd Compositions comprising bacterial strains
HUE044617T2 (en) 2015-06-15 2019-11-28 4D Pharma Res Ltd Compositions comprising bacterial strains
MA41010B1 (en) 2015-06-15 2020-01-31 4D Pharma Res Ltd Compositions comprising bacterial strains
GB201520497D0 (en) 2015-11-20 2016-01-06 4D Pharma Res Ltd Compositions comprising bacterial strains
MD3209310T2 (en) 2015-11-20 2018-06-30 4D Pharma Res Ltd Compositions comprising bacterial strains
CN114712405A (en) 2016-03-04 2022-07-08 4D制药有限公司 Compositions comprising bacterial strains
GB201612191D0 (en) 2016-07-13 2016-08-24 4D Pharma Plc Compositions comprising bacterial strains
TWI802545B (en) 2016-07-13 2023-05-21 英商４Ｄ製藥有限公司 Compositions comprising bacterial strains
GB201621123D0 (en) 2016-12-12 2017-01-25 4D Pharma Plc Compositions comprising bacterial strains
EP3630137B1 (en) 2017-05-22 2023-05-17 4D Pharma Research Limited Compositions comprising bacterial strains
MA41708A (en) 2017-05-24 2020-04-08 4D Pharma Res Ltd COMPOSITIONS CONTAINING BACTERIAL STRAINS
SI3638271T1 (en) 2017-06-14 2021-01-29 4D Pharma Research Limited Compositions comprising bacterial strains
PL3600364T3 (en) 2017-06-14 2021-01-11 4D Pharma Research Limited Compositions comprising a bacterial strain of the genus megasphaera and uses thereof

Also Published As

Publication number Publication date
WO1988007865A1 (en) 1988-10-20
AU604117B2 (en) 1990-12-06
PT87190A (en) 1988-05-01
FR2613624A1 (en) 1988-10-14
AU1578688A (en) 1988-11-04
JPH01503537A (en) 1989-11-30
FR2613624B1 (en) 1990-11-23
EP0309532A1 (en) 1989-04-05
ZA882426B (en) 1988-09-28
PT87190B (en) 1992-08-31

Similar Documents

Publication Publication Date Title
OA09023A (en) Pharmaceutical composition, which can be administered orally, intended to reduce the effects of b-lactams.
BE896205A (en) NOVEL PHARMACEUTICAL FORMULATIONS CONTAINING COENZYME Q10 SUITABLE FOR TOPICAL ADMINISTRATION
IE862554L (en) Pharmaceutical compositions
PT87820A (en) PROCESS FOR THE PREPARATION OF 1,2,3,5,6-TETRAHYDRO-PYRIDILE ANOF PYPERIDILE COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS THEREWI
MX9203263A (en) ANALGESICAL PHARMACEUTICAL COMPOSITION FOR NASAL ADMINISTRATION.
IT8619625A0 (en) PHARMACEUTICAL COMPOSITIONS FOR INHALATION.
IT1210666B (en) PERCUTANEOUS PHARMACEUTICAL PREPARATION FOR THE TREATMENT OF ANGINA PECTORIS
IT8621358A0 (en) PHARMACEUTICAL COMPOSITION ANALGESIC ADAPTIVITY.
ITMI912212A0 (en) SOLID PHARMACEUTICAL COMPOSITIONS FOR ORAL ADMINISTRATION WITH PROLONGED GASTRIC RESIDENCE
IT1190824B (en) PHARMACEUTICAL COMPOSITION CONTAINING 24.25-DIHYDROXICOLECALCIFEROL AS ACTIVE INGREDIENT
IT8119673A0 (en) PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF OSTEOPATHIES.
MA22443A1 (en) PROCESS FOR THE PREPARATION OF A PHARMACEUTICAL COMPOSITION.
FI883673A0 (en) PHARMACEUTICAL COMPOSITION.
ATE90339T1 (en) BASIC SUBSTITUTED PHENYLACETONITRILES, THEIR PREPARATION AND MEDICATIONS CONTAINING THEM.
IT8219482A0 (en) PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF ORAL CAVITY DISEASES.
JPS52108028A (en) Remedies for dysacousis
IT8722031A0 (en) PHARMACEUTICAL FORMULATIONS AND DOSAGE FORMS FOR THE RECTAL ADMINISTRATION OF CALCITONIN.
IT1210935B (en) PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF CARDIOVASCULAR DISEASES.
NO873514L (en) PROCEDURE FOR THE PREPARATION OF PHARMACEUTICAL ACTIVE COMPOUNDS.
OA06135A (en) Pharmaceutical composition for oral administration.
IT8722647A0 (en) PHARMACEUTICAL COMPOSITION FOR NASAL ADMINISTRATION.
OA08609A (en) Pharmaceutical composition for the treatment of bacterial infections.
IT8221120A0 (en) PHARMACEUTICAL COMPOSITION TO FIGHT PLATELEET AGGREGATION.
IT8720034A0 (en) PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF CEREBRAL PSYCHO-ORGANIC SYNDROMES.
BE810385A (en) DRUG COMPOSITIONS FOR ORAL ADMINISTRATION